urocanic acid has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boström, PJ; Laato, M; Laihia, JK; Leino, L; Pylkkänen, L | 1 |
| Arentsen, HC; Hulsbergen-van de Kaa, CA; Jansen, CF; Laihia, JK; Leino, L; Oosterwijk, E; Pylkkänen, L; Witjes, JA | 1 |
2 other study(ies) available for urocanic acid and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Epirubicin; Humans; Hydrogen-Ion Concentration; Paclitaxel; Photochemotherapy; Urinary Bladder Neoplasms; Urocanic Acid | 2009 |
Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder.
Topics: Animals; Carcinoma, Transitional Cell; Drug Screening Assays, Antitumor; Neoplasms, Experimental; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms; Urocanic Acid | 2012 |